← Evidence map

RetractedArticleMolecular medicine reports2018

Everolimus inhibits breast cancer cell growth through PI3K/AKT/mTOR signaling pathway.

Liyan Du et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

48 papers cite it

2018
2019
2020
2021
2022
2023
2024
2025
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 29568883